LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company") announces that it will ...
Pulmagen Therapeutics Competitors or Alternatives
Pulmagen Therapeutics's top competitors include Pulmatrix, Aerogen and Enterprise Therapeutics.
Pulmagen Therapeutics VS Aerogen
Aerogen is Pulmagen Therapeutics's #2 rival. Aerogen was founded in 1997 in Galway, County Galway. Aerogen operates in the Health Care Services industry. Aerogen generates $114.1M more revenue than Pulmagen Therapeutics.
Pulmagen Therapeutics VS Enterprise Therapeutics
Enterprise Therapeutics is a top competitor of Pulmagen Therapeutics. Enterprise Therapeutics is a Private company that was founded in Brighton, England in 2014. Enterprise Therapeutics is in the Pharmaceuticals field. Enterprise Therapeutics has 355 fewer employees vs. Pulmagen Therapeutics.
Looking for similar companies to Pulmagen Therapeutics?
Similar Companies
Companies in Slough with employees in 250-500 range
See 21 companies
Pharmaceuticals companies with employees in 250-500 rangeSee 341 companies
Companies in Slough with revenue in $100K-5.0M rangeSee 63 companies
Pharmaceuticals companies in EnglandSee 640 companies
Pharmaceuticals & Biotechnology companies with employees in 250-500 rangeSee 677 companies
Pharmaceuticals & Biotechnology companies in EnglandSee 1,390 companies
Pharmaceuticals companies in United KingdomSee 1,847 companies
Pharmaceuticals companies with revenue in $100K-5.0M rangeSee 2,203 companies
Pharmaceuticals & Biotechnology companies in United KingdomSee 3,378 companies
Trending News for Pulmagen Therapeutics and Pulmagen Therapeutics's Competitors
AstraZeneca Pharma India Ltd on Tuesday said it has surrendered the marketing authorisation of prostate cancer treatment drug Olaparib (Lynparza) 100mg...
The artificial tears market is estimated to be valued at USD 3.52 Bn in 2024 and is expected to reach USD 5.27 Bn by 2031. It is projected to grow at a...
Windtree Therapeutics, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was U...
Company Logo Photo: Terrence Horan The AstraZeneca PLC ADR AZN -1.21% COMP -3.07% DJIA -1.73% This was the ADR's second consecutive day of losses. Astr...
Global chronic obstructive pulmonary disease treatment market is estimated to be valued at USD 20.35 Bn in 2025 and is expected to reach USD 30.41 Bn b...
The latest report (2025-2032) on the Small Molecule Anti Infective Drug Market by Coherent Market Insights delivers a deep dive into key market trends,...
BNP Paribas Exane initiated coverage of AstraZeneca ( AZN ) with an Outperform rating and $75 price target Stay Ahead of the Market: Discover outperfor...
Frequently Asked Questions about Pulmagen Therapeutics
Who are Pulmagen Therapeutics's top competitors?
Pulmagen Therapeutics's top 3 competitors are Pulmatrix, Aerogen, Enterprise Therapeutics.Who is similar to Pulmagen Therapeutics?
Pulmatrix is the most similar to Pulmagen Therapeutics. Aerogen and Enterprise Therapeutics are also similar to Pulmagen Therapeutics.
Are Pulmagen Therapeutics and Pulmatrix competitors?
Yes, Pulmatrix is one of Pulmagen Therapeutics’s top competitors.